FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

18712011000036105: Karvezide 150/12.5 (hydrochlorothiazide 12.5 mg + irbesartan 150 mg) tablet, 30 tablets, bottle (containered trade product pack)


Status: current, Defined. Date: 30-Jun 2009. Module: Australian Medicines Terminology module

Descriptions:

Id Description Lang Type Status Case? Module
3668881000168111 Karvezide 150/12.5 tablet, 30, bottle en Synonym Active Case sensitive Australian Medicines Terminology module
3668891000168114 Karvezide 150/12.5 (hydrochlorothiazide 12.5 mg + irbesartan 150 mg) tablet, 30 tablets, bottle (containered trade product pack) en Fully specified name Active Case sensitive Australian Medicines Terminology module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Karvezide 150/12.5 tablet, 30, bottle has TPUU Karvezide 150/12.5 tablet true Inferred relationship Some 1
Karvezide 150/12.5 tablet, 30, bottle Is a Karvezide 150/12.5 tablet, 30 true Inferred relationship Some
Karvezide 150/12.5 tablet, 30, bottle has TP Karvezide 150/12.5 true Inferred relationship Some
Karvezide 150/12.5 tablet, 30, bottle Is a containered trade product pack true Inferred relationship Some
Karvezide 150/12.5 tablet, 30, bottle Is a Karvezide 150/12.5 film-coated tablet, 30 false Inferred relationship Some
Karvezide 150/12.5 tablet, 30, bottle has container type bottle true Inferred relationship Some
Karvezide 150/12.5 tablet, 30, bottle has TPUU Karvezide 150/12.5 film-coated tablet false Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group

Reference Sets

Australian Register of Therapeutic Goods identifier reference set (foundation metadata concept)

Containered trade product pack reference set

Back to Start